These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 34167531)

  • 21. Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease.
    Elsaid MI; Li Y; Bridges JFP; Brock G; Minacapelli CD; Rustgi VK
    JAMA Netw Open; 2022 Oct; 5(10):e2235003. PubMed ID: 36205997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012.
    McCarty TR; Echouffo-Tcheugui JB; Lange A; Haque L; Njei B
    Surg Obes Relat Dis; 2018 Jan; 14(1):74-80. PubMed ID: 29055669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.
    Fakhry TK; Mhaskar R; Schwitalla T; Muradova E; Gonzalvo JP; Murr MM
    Surg Obes Relat Dis; 2019 Mar; 15(3):502-511. PubMed ID: 30683512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.
    Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K
    Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weight Loss After Bariatric Surgery Predicts an Improvement in the Non-alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score.
    Yeo SC; Ong WM; Cheng KSA; Tan CH
    Obes Surg; 2019 Apr; 29(4):1295-1300. PubMed ID: 30635812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
    Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
    Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of NASH with Gastric Bypass.
    Jirapinyo P; Thompson CC
    Curr Gastroenterol Rep; 2018 Sep; 20(10):49. PubMed ID: 30244334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Non-Alcoholic Fatty Liver Disease on Weight Loss and Resolution of Obesity-Related Disorders After Bariatric Surgery.
    Abdalla TSA; Giannou AD; Abdalla ASA; Izbicki JR; Dupreé A; Mann O; Wolter S
    World J Surg; 2023 Dec; 47(12):3281-3288. PubMed ID: 37747548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up.
    Norouzian Ostad A; Rajabzadeh F; Jamialahmadi T; Goshayeshi L; Ranjbar G; Rezvani R; Nematy M; Jangjoo A
    Updates Surg; 2023 Apr; 75(3):659-669. PubMed ID: 36529770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study).
    Lavín-Alconero L; Fernández-Lanas T; Iruzubieta-Coz P; Arias-Loste MT; Rodriguez-Duque JC; Rivas C; Cagigal ML; Montalbán C; Useros AL; Álvarez-Cancelo A; García-Saiz M; Crespo-García J
    Trials; 2021 Oct; 22(1):756. PubMed ID: 34717726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Bariatric Surgery on Non-alcoholic Fatty Liver Disease: Magnetic Resonance Imaging Is an Effective, Non-invasive Method to Evaluate Changes in the Liver Fat Fraction.
    Hedderich DM; Hasenberg T; Haneder S; Schoenberg SO; Kücükoglu Ö; Canbay A; Otto M
    Obes Surg; 2017 Jul; 27(7):1755-1762. PubMed ID: 28064372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Liver Disease on Perioperative Outcome After Bariatric Surgery in a Northern German Cohort.
    Wolter S; Duprée A; Coelius C; El Gammal A; Kluwe J; Sauer N; Mann O
    Obes Surg; 2017 Jan; 27(1):90-95. PubMed ID: 27272667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis.
    Lee Y; Doumouras AG; Yu J; Brar K; Banfield L; Gmora S; Anvari M; Hong D
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1040-1060.e11. PubMed ID: 30326299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bariatric surgery during the evolution of fatty liver-A randomized clinical trial comparing gastric bypass and sleeve gastrectomy based on transient elastography.
    de Barros F; Fonseca ABM
    Clin Obes; 2020 Dec; 10(6):e12393. PubMed ID: 32885600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease.
    Perysinakis I; Pappis HC; Margaris E
    Obes Surg; 2019 Mar; 29(3):1058-1067. PubMed ID: 30617917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
    Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
    JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?
    Hafeez S; Ahmed MH
    J Obes; 2013; 2013():839275. PubMed ID: 23431426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.